Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma

Clinical Trial ID NCT00791544

PubWeight™ 12.36‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00791544

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010 5.90
2 The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2010 2.07
3 Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012 1.55
4 Targeting the insulin-like growth factor pathway in hepatocellular carcinoma. World J Hepatol 2014 0.87
5 Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol 2013 0.83
6 Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma. BMC Cancer 2010 0.79
7 The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets. Infect Agent Cancer 2014 0.78
Next 100